The board members of gene-sequencing company Illumina Inc. (ILMN) unanimously rejected a takeover bid from drug maker Roche Holding AG (ROG.VX, RHHBY), calling the Swiss company's offer inadequate. The takeover target also said its fourth-quarter earnings dropped 70% as one-time...